FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Carbidopa and Levodopa Extended Release Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Merck Sharp & Dohme Corp. (New 07/17/2019)

Company Contact Information:
800-637-2579

Presentation Posting Date Related Information
Carbidopa levodopa (50 mg of carbidopa and 200 mg of levodopa) (SINEMET CR 50-200) sustained-release tablets, (NDC 0006-3919-68)bottles of 100 07/17/2019 To be discontinued on or near November 2019.
Carbidopa levodopa (25 mg of carbidopa and 100 mg of levodopa) (SINEMET CR 25-100 ) sustained-release tablets, (NDC 0006-3918-68) bottles of 100 N/A To be discontinued on or near February 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English